Abolishing cell wall glycosylphosphatidylinositol-anchored proteins in Candida albicans enhances recognition by host Dectin-1

Infection and Immunity

Volumn 83, Issue 7, 2015, Pages 2694-2704

  Shen, Hui ^a   Chen, Si Min ^a   Liu, Wei ^a   Zhu, Fang ^a   He, Li Juan ^b   Zhang, Jun Dong ^a   Zhang, Shi Qun ^a   Yan, Lan ^b   Xu, Zheng ^b   Xu, Guo Tong ^a   An, Mao Mao ^a   Jiang, Yuan Ying ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; DECTIN 1; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 6; MANNOSE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOETHANOLAMINE; TUMOR NECROSIS FACTOR ALPHA; BETA GLUCAN; BETA-1,3-GLUCAN; FUNGAL PROTEIN; FUNGUS ANTIGEN; LECTIN; PHOSPHOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FUNGAL CELL WALL; FUNGAL GENE; GENE DELETION; GPI7 GENE; HOST; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RESPIRATORY BURST; TH1 CELL; TH17 CELL; ANIMAL; C57BL MOUSE; CELL WALL; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM;

ANIMALS; ANTIGENS, FUNGAL; BETA-GLUCANS; CANDIDA ALBICANS; CELL WALL; FEMALE; FUNGAL PROTEINS; GENE DELETION; GLYCOSYLPHOSPHATIDYLINOSITOLS; LECTINS, C-TYPE; MACROPHAGES; MICE, INBRED C57BL; NEUTROPHILS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 84930988723     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00097-15     Document Type: Article

References (60)

1. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. 2012. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112-122. http://dx.doi.org/10.1038 /nrmicro2711.
2. Miceli M, Díaz J, Lee S. 2011. Emerging opportunistic yeast infections. Lancet Infect Dis 11:142-151. http://dx.doi.org/10.1016/S1473-3099(10) 70218-8.
3. Hsu FC, Lin PC, Chi CY, Ho MW, Ho CM, Wang JH. 2009. Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery. J Microbiol Immunol Infect 42:378-384.
4. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48:1695-1703. http: //dx.doi.org/10.1086/599039.
5. Romani L. 2011. Immunity to fungal infections. Nat Rev Immunol 11: 275-288. http://dx.doi.org/10.1038/nri2939.
6. Brown GD. 2011. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 29:1-21. http://dx.doi.org/10.1146/annurev-immunol -030409-101229.
7. Wüthrich M, Deepe GS, Jr, Klein B. 2012. Adaptive immunity to fungi. Annu Rev Immunol 30:115-148. http://dx.doi.org/10.1146/annurev -immunol-020711-074958.
8. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8:31-38. http://dx.doi.org/10.1038/ni1408.
9. Heinsbroek SE, Brown GD, Gordon S. 2005. Dectin-1 escape by fungal dimorphism. Trends Immunol 26:352-354. http://dx.doi.org/10.1016/j.it .2005.05.005.
10. Gantner BN, Simmons RM, Underhill DM. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24:1277-1286. http://dx.doi.org/10.1038/sj.emboj.7600594.
11. Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, Bose N, Chan AS, Magee AS, Danielson ME, Weiss A, Vasilakos JP, Underhill DM. 2011. Activation of the innate immune receptor Dectin-1 upon formation of a "phagocytic synapse." Nature 472:471-475. http://dx .doi.org/10.1038/nature10071.
12. Tam JM, Mansour MK, Khan NS, Seward M, Puranam S, Tanne A, Sokolovska A, Becker CE, Acharya M, Baird MA, Choi AM, Davidson MW, Segal BH, Lacy-Hulbert A, Stuart LM, Xavier RJ, Vyas JM. 2014. Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J Infect Dis 210:1844-1854. http://dx.doi.org/10 .1093/infdis/jiu290.
13. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, Masthoff L, Morré SA, Vriend G, Williams DL, Perfect JR, Joosten LA, Wijmenga C, van der Meer JW, Adema GJ, Kullberg BJ, Brown GD, Netea MG. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections.NEngl J Med 361:1760-1767. http: //dx.doi.org/10.1056/NEJMoa0901053.
14. Wheeler RT, Kombe D, Agarwala SD, Fink GR. 2008. Dynamic, morphotype- specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog 4:e1000227. http://dx.doi.org/10.1371 /journal.ppat.1000227.
15. Chaffin WL. 2008. Candida albicans cell wall proteins. Microbiol Mol Biol Rev 72:495-544. http://dx.doi.org/10.1128/MMBR.00032-07.
16. Richard ML, Plaine A. 2007. Comprehensive analysis of glycosylphosphatidylinositol- anchored proteins in Candida albicans. Eukaryot Cell 6:119-133. http://dx.doi.org/10.1128/EC.00297-06.
17. Richard M, Ibata-Ombetta S, Dromer F, Bordon-Pallier F, Jouault T, Gaillardin C. 2002. Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages. Mol Microbiol 44:841-853. http://dx.doi.org/10 .1046/j.1365-2958.2002.02926.x.
18. Hoyer LL. 2001. The ALS gene family of Candida albicans. Trends Microbiol 9:176-180. http://dx.doi.org/10.1016/S0966-842X(01)01984-9.
19. Fonzi WA. 1999. PHR1 and PHR2 of Candida albicans encodes putativeglycosidases required for proper cross-linking of beta-1,3- and beta-1,6- glucans. J Bacteriol 181:7070-7079.
20. Staab JF, Bradway SD, Fidel PL, Sundstrom P. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538. http://dx.doi.org/10.1126/science.283 .5407.1535.
21. Martinez-Lopez R, Park H, Myers CL, Gil C, Filler SG. 2006. Candida albicans Ecm33p is important for normal cell wall architecture and interactions with host cells. Eukaryot Cell 5:140-147. http://dx.doi.org/10 .1128/EC.5.1.140-147.2006.
22. Fu Y, Ibrahim AS, Sheppard DC, Chen YC, French SW, Cutler JE, Filler SG, Edwards JE, Jr. 2002. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol 44:61-72. http://dx.doi.org/10.1046/j.1365-2958.2002.02873.x.
23. Zhao X, Daniels KJ, Oh SH, Green CB, Yeater KM, Soll DR, Hoyer LL. 2006. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152:2287-2299. http://dx .doi.org/10.1099/mic.0.28959-0.
24. McLellan CA, Whitesell L, King OD, Lancaster AK, Mazitschek R, Lindquist S. 2012. Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity. ACS Chem Biol 7:1520-1528. http://dx.doi.org/10.1021/cb300235m.
25. Vautier S, Drummond RA, Redelinghuys P, Murray GI, MacCallum DM, Brown GD. 2012. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun 80:4216- 4222. http://dx.doi.org/10.1128/IAI.00559-12.
26. Yan L, Côte P, Li XX, Jiang YY, Whiteway M. 2012. PalI domain proteins of Saccharomyces cerevisiae and Candida albicans. Microbiol Res 167:422-432. http://dx.doi.org/10.1016/j.micres.2011.12.005.
27. Noble SM, Johnson AD. 2005. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell 4:298-309. http://dx.doi.org/10.1128/EC.4.2.298-309.2005.
28. Reuss O, Vik A, Kolter R, Morschhäuser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119- 127. http://dx.doi.org/10.1016/j.gene.2004.06.021.
29. Klis FM, de Koster CG, Brul S. 2011. A mass spectrometric view of the fungal wall proteome. Future Microbiol 6:941-951. http://dx.doi.org/10 .2217/fmb.11.72.
30. Castillo L, Calvo E, Martínez AI, Ruiz-Herrera J, Valentín E, Lopez JA, Sentandreu R. 2008. A study of the Candida albicans cell wall proteome. Proteomics 8:3871-3781. http://dx.doi.org/10.1002/pmic.200800110.
31. Hamada K, Terashima H, Arisawa M, Kitada K. 1998. Amino acid sequence requirement for efficient incorporation of glycosylphosphatidylinositol- associated proteins into the cell wall of Saccharomyces cerevisiae. J Biol Chem 273:26946 -26953. http://dx.doi.org/10 .1074/jbc.273.41.26946.
32. Kapteyn JC, Hoyer LL, Hecht JE, Müller WH, Andel A, Verkleij AJ, Makarow M, Van Den Ende H, Klis FM. 2000. The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol Microbiol 35:601-611. http://dx.doi.org/10.1046/j.1365-2958.2000.01729.x.
33. Wheeler RT, Fink GR. 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2:e35. http://dx.doi.org/10 .1371/journal.ppat.0020035.
34. Imhof I, Flury I, Vionnet C, Roubaty C, Egger D, Conzelmann A. 2004. Glycosylphosphatidylinositol (GPI) proteins of Saccharomyces cerevisiae contain ethanolamine phosphate groups on the alpha1,4-linked mannose of the GPI anchor. J Biol Chem 279:19614-19627. http://dx.doi.org/10 .1074/jbc.M401873200.
35. Davis SE, Hopke A, Minkin SC, Jr, Montedonico AE, Wheeler RT, Reynolds TB. 2014. Masking of β(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine. Infect Immun 82:4405-4413. http://dx.doi.org/10.1128/IAI .01612-14.
36. Low CY, Rotstein C. 2011. Emerging fungal infections in immunocompromised patients. F1000 Med Rep 3:14. http://dx.doi.org/10.3410/M3-14.
37. Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR. 2007. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 37:467- 478. http://dx.doi.org/10.1002/eji .200636653.
38. Netea MG, Brown GD, Kullberg BJ, Gow NA. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6:67-78. http://dx.doi.org/10.1038/nrmicro1815.
39. Poulain D, Jouault T. 2004. Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk. Curr Opin Microbiol 7:342-349. http://dx.doi.org/10.1016/j.mib.2004.06.011.
40. Galán-Díez M, Arana DM, Serrano-Gómez D, Kremer L, Casasnovas JM, Ortega M, Cuesta-Domínguez A, Corbí AL, Pla J, Fernández-Ruiz E. 2010. Candida albicans beta-glucan exposure is controlled by the fungal CEK1-mediated mitogen-activated protein kinase pathway that modulates immune responses triggered through dectin-1. Infect Immun 78: 1426-1436. http://dx.doi.org/10.1128/IAI.00989-09.
41. Klis FM, Sosinska GJ, de Groot PW, Brul S. 2009. Covalently linked cell wall proteins of Candida albicans and their role in fitness and virulence. FEMS Yeast Res 9:1013-1028. http://dx.doi.org/10.1111/j.1567-1364 .2009.00541.x.
42. Rappleye CA, Eissenberg LG, Goldman WE. 2007. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the betaglucan receptor. Proc Natl Acad Sci U S A 104:1366-1370. http://dx.doi .org/10.1073/pnas.0609848104.
43. Edwards JA, Alore EA, Rappleye CA. 2011. The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot Cell 10:87-97. http://dx.doi.org/10.1128/EC .00214-10.
44. Goodridge HS, Wolf AJ, Underhill DM. 2009. Beta-glucan recognition by the innate immune system. Immunol Rev 230:38-50. http://dx.doi.org /10.1111/j.1600-065X.2009.00793.x.
45. Arendrup MC. 2010. Epidemiology of invasive candidiasis. Curr Opin Crit Care 16:445-452. http://dx.doi.org/10.1097/MCC.0b013e32833e84d2.
46. Gazendam RP, van Hamme JL, Tool AT, van Houdt M, Verkuijlen PJ, Herbst M, Liese JG, van de Veerdonk FL, Roos D, van den Berg TK, Kuijpers TW. 2014. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood 124:590-597. http://dx.doi.org/10.1182/blood-2014-01-551473.
47. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630-638. http://dx.doi.org/10.1038/ni1460.
48. Basu S, Quilici C, Zhang HH, Grail D, Dunn AR. 2008. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans. Growth Factors 26:23-34. http://dx.doi.org/10.1080/08977190801987513.
49. Netea MG, van Tits LJ, Curfs JH, Amiot F, Meis JF, van der Meer JW, Kullberg BJ. 1999. Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruit- ment of neutrophils and phagocytosis of Candida albicans. J Immunol 163:1498-1505.
50. Plaine A, Yáñez A, Murciano C, Gaillardin C, Gil ML, Richard ML, Gozalbo D. 2008. Enhanced proinflammatory response to the Candida albicans gpi7 null mutant by murine cells. Microbes Infect 10:382-389. http://dx.doi.org/10.1016/j.micinf.2007.12.018.
51. Marques da Silva C, Miranda Rodrigues L, Passos da Silva Gomes A, Mantuano Barradas M, Sarmento Vieira F, Persechini PM, Coutinho- Silva R. 2008. Modulation of P2X7 receptor expression in macrophages from mineral oil-injected mice. Immunobiology 213:481-492. http://dx .doi.org/10.1016/j.imbio.2007.11.006.
52. Cockrell A, Laroux FS, Jourd'heuil D, Kawachi S, Gray L, Van der Heyde H, Grisham MB. 1999. Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. Biochem Biophys Res Commun 257:684- 686. http://dx.doi.org/10.1006/bbrc.1999.0484.
53. Odds FC. 1988. Candida and candidosis. Baillere-Tindall, London, United Kingdom.
54. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190:624-631. http://dx.doi.org/10.1086/422329.
55. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311. http://dx.doi.org/10.1084/jem.20081463.
56. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. 2010. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681-691. http://dx.doi.org/10.1016/j .immuni.2010.05.001.
57. Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM. 1991. Myeloid cell kinetics in mice treated with recombinant interleukin- 3, granulocyte colony-stimulating factor (CSF), or granulocytemacrophage CSF in vivo. Blood 77:2154-2159.
58. Weisbart RH, Kwan L, Golde DW, Gasson JC. 1987. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69:18-21.
59. Metcalf D, Begley CG, Williamson DJ, Nice EC, De Lamarter J, Mermod JJ, Thatcher D, Schmidt A. 1987. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol 15:1-9.
60. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RA. 1997. Monocyte chemoattractant protein-1 mediates monocyte/ macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51:770-776. http://dx.doi.org/10.1038/ki .1997.108.